If you are a longevity and lifestyle medicine provider who prescribes semaglutides as part of a weight management protocol, you and your current/prospective patients, may be affected by the FDA announcement on February 21, 2025 that the semaglutide shortage has been resolved.  In short, this means that compounded semaglutide meds that have been on the market will no longer be available as they have been

The authors of a recent article finally named and defined something that has been plaguing women for a very long time. By signaling that a set of symptoms so many people suffer from may be related to perimenopause or menopause, many more women have the chance to find relief from both musculoskeletal pain and the psychological effects of unsuccessful treatments.